ABHD1
Protein ABHD1
Also known as: ABHD1_HUMAN, FLJ36128, LABH1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96SE0
- Gene
- ABHD1
- Ensembl
- ENSG00000143994
- Chromosome
- 2
- Canonical length
- 405 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins
OverviewNCBI Gene
This gene is a member of the AB hydrolase superfamily and encodes a protein with an alpha/beta hydrolase fold. This domain is common to a number of hydrolytic enzymes of widely differing phylogenetic origins and catalytic functions. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
405 residues, UniProt reviewed canonical sequence.
>Q96SE0|ABHD1
1 MLSSFLSPQN GTWADTFSLL LALAVALYLG YYWACVLQRP RLVAGPQFLA FLEPHCSITT
61 ETFYPTLWCF EGRLQSIFQV LLQSQPLVLY QSDILQTPDG GQLLLDWAKQ PDSSQDPDPT
121 TQPIVLLLPG ITGSSQETYV LHLVNQALRD GYQAVVFNNR GCRGEELRTH RAFCASNTED
181 LETVVNHIKH RYPQAPLLAV GISFGGILVL NHLAQARQAA GLVAALTLSA CWDSFETTRS
241 LETPLNSLLF NQPLTAGLCQ LVERNRKVIE KVVDIDFVLQ ARTIRQFDER YTSVAFGYQD
301 CVTYYKAASP RTKIDAIRIP VLYLSAADDP FSPVCALPIQ AAQHSPYVAL LITARGGHIG
361 FLEGLLPWQH WYMSRLLHQY AKAIFQDPEG LPDLRALLPS EDRNSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ABHD1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Unknown
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 20 nTPM
Expression across tissuesHPA
Tissue
- testis: 20 nTPM
- liver: 3.1 nTPM
- skeletal muscle: 1.8 nTPM
- tongue: 1.6 nTPM
- salivary gland: 1.4 nTPM
- adipose tissue: 1.1 nTPM
Single-cell type
- late spermatids: 1,933 nCPM
- early spermatids: 300 nCPM
- late primary spermatocytes: 223 nCPM
- myonuclei: 19 nCPM
- cone photoreceptor cells: 10 nCPM
- epididymal principal cells: 7.8 nCPM
Immune cell
- eosinophil: 0.8 nTPM
- gdT-cell: 0.6 nTPM
- memory B-cell: 0.5 nTPM
- memory CD4 T-cell: 0.3 nTPM
- memory CD8 T-cell: 0.3 nTPM
- naive B-cell: 0.3 nTPM
Brain region
- cerebellum: 3 nTPM
- cerebral cortex: 2.1 nTPM
- thalamus: 1.8 nTPM
- medulla oblongata: 1.7 nTPM
- pons: 1.7 nTPM
- spinal cord: 1.7 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.91
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.95
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ABHD1 as an antibody target. Whether an autoantibody or antibody against ABHD1 could matter depends on whether native ABHD1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ABHD1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ABHD1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...